KREBSBIOKREBSBIO:- The stock has been falling for 2 years, a triangle pattern has been formed, if we get an upside breakout then we may see good movement.
Hello traders,
As always, simple and neat charts so everyone can understand and not make it too complicated.
rest details mentioned in the chart.
w
−9.66INR
−246.92 MINR
525.34 MINR
About KREBS BIOCHEMICALS & INDUSTRIE
Sector
CEO
Jitendra Shah
Headquarters
Hyderabad
Website
Employees (FY)
210
Founded
1991
ISIN
INE268B01013
FIGI
BBG000DC0GS2
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. Its products include Androstenedione, Lovastatin, and Simvastatin. The company was founded by Ravindranath Tagore Ravi on December 2, 1991 and is headquartered in Hyderabad, India.
#KREBSBIO KREBSBIO #NIFTY BANKNIFTY #NSE #BSE #HDFCBANK #SBIN Krebs Biochemicals And Industries Ltd.
NSE:KREBSBIO
NSE:KREBSBIO
CMP: 175.40
Target: 250+
Time frame: < 6months
SL: 148
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KREBSBIO is 70.65 INR — it has decreased by 1.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange KREBS BIOCHEMICALS & INDUSTRIE stocks are traded under the ticker KREBSBIO.
KREBSBIO stock is 2.61% volatile and has beta coefficient of 0.02. Check out the list of the most volatile stocks — is KREBS BIOCHEMICALS & INDUSTRIE there?
Yes, you can track KREBS BIOCHEMICALS & INDUSTRIE financials in yearly and quarterly reports right on TradingView.
KREBSBIO stock has fallen by 1.87% compared to the previous week, the month change is a 9.20% rise, over the last year KREBS BIOCHEMICALS & INDUSTRIE has showed a 6.79% decrease.
KREBSBIO net income for the last quarter is −49.77 M INR, while the quarter before that showed −35.71 M INR of net income which accounts for −39.37% change. Track more KREBS BIOCHEMICALS & INDUSTRIE financial stats to get the full picture.
Today KREBS BIOCHEMICALS & INDUSTRIE has the market capitalization of 1.55 B, it has increased by 10.86% over the last week.
No, KREBSBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KREBSBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KREBS BIOCHEMICALS & INDUSTRIE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 210.00 employees. See our rating of the largest employees — is KREBS BIOCHEMICALS & INDUSTRIE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KREBS BIOCHEMICALS & INDUSTRIE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KREBS BIOCHEMICALS & INDUSTRIE stock shows the sell signal. See more of KREBS BIOCHEMICALS & INDUSTRIE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KREBS BIOCHEMICALS & INDUSTRIE EBITDA is −102.35 M INR, and current EBITDA margin is −29.28%. See more stats in KREBS BIOCHEMICALS & INDUSTRIE financial statements.